title: Novel Applications of Modified Ultrafiltration and Autologous Priming Techniques to Reduce Blood Product Exposure on ECMO.
abstract: Patients needing the assistance of extracorporeal membrane oxygenation (ECMO) are at risk of hemodilution and, in some instances, may require exposure to large amounts of allogeneic blood products. Patient outcomes can be improved by taking steps to reduce transfusions and hemodilution. Currently, modified ultrafiltration (MUF) is used across the world to reduce hemodilution after cardiopulmonary bypass (CPB). Another common technique during bypass initiation is autologous priming. By applying modified versions of these techniques, ECMO patients may potentially benefit. Usually, patients requiring immediate transition from CPB to ECMO are not stable enough to tolerate MUF. Through alterations of the CPB and ECMO circuit tubing, MUF can be performed once on ECMO. Another technique to potentially lower the transfusion requirements for ECMO patients is a complete circuit blood transfer during an ECMO circuit exchange. While selective component changes are preferred if possible, occasionally a complete circuit change must be done. To minimize hemodilution or prevent priming with blood products, the original ECMO circuit's blood can be transferred to the new ECMO circuit before connecting to the patient. Both of these techniques, in our opinion, helped to reduce the number of transfusions that our ECMO patients have seen during these critical time periods.
authors.affiliation: Cardiovascular Perfusion Services, Mayo Clinic, Rochester, Minnesota.
authors.forename: James R
authors.initials: JR
authors.lastname: Neal
authors.affiliation: Cardiovascular Perfusion Services, Mayo Clinic, Rochester, Minnesota.
authors.forename: Caitlin L
authors.initials: CL
authors.lastname: Blau
authors.affiliation: Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Cornelius
authors.affiliation: Division of Anesthesiology and Critical Care, Mayo Clinic, Rochester, Minnesota.
authors.forename: Roxann B
authors.initials: RB
authors.lastname: Pike
authors.affiliation: Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Dearani
authors.affiliation: Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
authors.forename: Bassem N
authors.initials: BN
authors.lastname: Mora
mesh_terms: D001803:Blood Transfusion / Q000706:statistics & numerical data; D002315:Cardiopulmonary Bypass / Q000379:methods; D004867:Equipment Design; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D006438:Hemodilution / Q000706:statistics & numerical data; D006440:Hemofiltration / Q000295:instrumentation / Q000379:methods; D006801:Humans; D014462:Ultrafiltration / Q000295:instrumentation / Q000379:methods; D062666:Vascular Access Devices
keywords: autologous priming; blood conservation; extracorporeal membrane oxygenation; modified ultrafiltration